The conference which has been postponed due to Covid-19, will now take place from 26th to 28th October 2020 in Bethesda, MD.
The event venue and format will remain unchanged, and any upcoming programme alterations will be listed on the event website.
The 2020 programme will focus on industry influencers, safety assessment strategies and analytical challenges in extractables and leachables profiling: Quantitation and identification, regulatory updates, the global landscape, the role of chemical characterisation in establishing the biocompatibility of medical devices, analytical advances, and case studies.
There will be presenters from multiple organisations, including but not limited to: FDA, Baxter International, Intertek, Becton Dickinson, ELSIE, D&B ChemTox, Nelson Labs, and Jordi Labs.
Event poster sessions will also aim to provide a platform for industry and academic experts to briefly share their technical research, testing results, and latest case studies with an audience of extractables and leachables professionals from across the supply chain.
Alongside the presentations, attendees will have the opportunity to build relationships with others in the industry through networking during breaks, lunch times and an evening reception.
Previous companies who have attended include B Braun, FDA, Toxikon, Intertek, Abbott, Nelson Laboratories, Boston Scientific, Vimta, Jordi Labs, VR Analytical, and Teknor Apex.
To register for this event, and for more information, please see the event website.